IPB

Innovative Pharmaceutical Biotech Limited ("IPB") has two primary segments of business: the research and development of pharmaceutical products and trading of beauty equipment and products. Currently, IPB is focused on developing an insulin product that could be administered orally. The company is keen to expand its research and development segment by acquiring additional pharmaceutical products with commercial viability.

Also known as: Innovative Pharmaceutical Biotech Limited

Primary location: Hamilton Bermuda